)
Max Healthcare Institute (543220) investor relations material
Max Healthcare Institute Q4 25/26 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Phased commissioning of over 20% additional brownfield capacity across Mohali, Nanavati (Mumbai), and Max Smart (Delhi) in the last two quarters, with all beds to be operational in the next 2-3 months; another 10% capacity expected from Gurugram later in 2026.
Acquisition of a controlling 58.28% stake in Kalinga Hospital (Bhubaneswar) completed in May 2026, marking entry into Eastern India and providing a platform for future expansion.
Board approved INR 1,400 crore investment for a new 700-712 bed greenfield hospital at Shaheed Path, Lucknow, to be commissioned by FY30.
22nd consecutive quarter of year-on-year growth, with FY26 gross revenue up 16% YoY to INR 10,538 crore, operating EBITDA up 14% YoY to INR 2,638 crore, and PAT after exceptional items up 22% YoY to INR 1,631 crore.
Final dividend of ₹2 per equity share recommended, subject to shareholder approval.
Financial highlights
Q4 FY26 gross revenue: INR 2,664 crore (+10% YoY, +2% QoQ); operating EBITDA: INR 682 crore (+8% YoY, +5% QoQ); EBITDA margin: 26.8%.
FY26 gross revenue: INR 10,538 crore (+16% YoY); operating EBITDA: INR 2,638 crore (+14% YoY); EBITDA margin: 26.2%.
Q4 profit after tax: INR 387 crore, up from INR 376 crore YoY and INR 344 crore QoQ.
Free cash flow in Q4: INR 581 crore; net debt at FY26 end: INR 1,908 crore (net debt/EBITDA < 1); cash from operations: INR 1,541 crore.
Pre-tax ROCE: 20.9% in Q4 FY26 (vs 23.8% Q4 FY25); 21.8% in FY26 (vs 25.9% FY25).
Outlook and guidance
Focus on scaling newly commissioned capacities, integrating Kalinga Hospital, and progressing expansion projects including Sector 56 Gurgaon and Lucknow.
500-bed Gurgaon hospital to be commissioned by end of FY27, with phased operationalization starting at ~200 beds; 712-bed Lucknow hospital expected by FY30.
Additional brownfield/asset-light expansions planned in Pune, Dwarka, Dehradun, and other locations.
Expect operating leverage as new beds ramp up occupancy; no major regulatory delays anticipated for upcoming projects.
- Q2 FY26 delivered 21% revenue and 23% EBITDA growth, driven by expansion and digital gains.543220
Q2 25/268 Jul 2026 - FY25 revenue rose 26% YoY to INR 9,065 Cr, with robust EBITDA growth and major expansions.543220
Q4 24/258 Jul 2026 - Q1 FY25 saw 18% revenue growth, high occupancy, and strong expansion momentum.543220
Q1 24/258 Jul 2026 - Q3 FY25 revenue rose 34% with strong EBITDA, major expansions, and Jaypee Healthcare acquisition.543220
Q3 24/258 Jul 2026 - Q3 FY26 delivered strong growth, with expansion, digital gains, and regulatory impacts shaping outlook.543220
Q3 25/2612 Apr 2026 - Strong revenue and EBITDA growth, major acquisitions, and expansion marked the quarter.543220
Q2 24/2516 Jan 2026 - Revenue up 27% YoY, EBITDA up 23%, and PAT up 17% amid robust expansion and digital growth.543220
Q1 25/2623 Nov 2025
Next Max Healthcare Institute earnings date
Next Max Healthcare Institute earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)